Literature DB >> 12404200

The role of plasma fatty acid composition in endogenous glucose production in patients with type 2 diabetes mellitus.

John N Clore1, James Allred, Danielle White, Jing Li, Julie Stillman.   

Abstract

Hepatic insulin resistance and increased endogenous glucose production (EGP) are associated with increased plasma free fatty acids (FFA). However, the contribution of FFA composition to the regulation of EGP is not known. Six obese nondiabetic subjects and 6 patients with type 2 diabetes mellitus (DM2) were studied after an overnight and a 3-day fast. Plasma insulin concentrations after an overnight fast were similar in the DM2 and nondiabetic patients (88.8 +/- 26.4 v 57.6 +/- 12.6 pmol/L, not significant [NS]) despite increased plasma glucose (9.9 +/- 1.8 v 5.1 +/- 0.1 mmol/L, P <.01) and EGP (510.3 +/- 77.7 v 298.3 +/- 18.3 micromol x m(-2) x min(-1), P <.05) in the patients with DM2. Absolute rates of gluconeogenesis using the heavy water method were also increased in the patients with DM2 (346.8 +/- 74.9 v 198.8 +/- 16.4 micromol x m(-2). min(-1), P <.05). No differences were observed in plasma polyunsaturated fatty acids (PUFA) between the diabetic and nondiabetic subjects. However, total saturated fatty acid (SFA) concentrations (350 +/- 37.4 v 230.9 +/- 33.3 micromol/L, P <.02) were significantly increased in the diabetic subjects. Rates of EGP were correlated with total plasma FFA concentration (r =.71, P <.01) and the concentration of SFA (r =.71, P <.01), but not monounsaturated fatty acids or PUFA. Rates of gluconeogenesis were also correlated with plasma FFA (r =.64, P <.05) and SFA (r =.67, P <.05). We observed no relationship between EGP and either total FFA or fatty acid composition after a 3-day fast. We conclude that increases in EGP are associated with concentrations of plasma SFA after an overnight fast. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404200     DOI: 10.1053/meta.2002.35202

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  27 in total

1.  Palmitic Acid-Induced NAD+ Depletion is Associated with the Reduced Function of SIRT1 and Increased Expression of BACE1 in Hippocampal Neurons.

Authors:  Manuel Flores-León; Martha Pérez-Domínguez; Rodrigo González-Barrios; Clorinda Arias
Journal:  Neurochem Res       Date:  2019-05-09       Impact factor: 3.996

2.  IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate.

Authors:  Lauren Boland; Anthony J Burand; Alex J Brown; Devlin Boyt; Vitor A Lira; James A Ankrum
Journal:  Mol Ther       Date:  2017-12-19       Impact factor: 11.454

3.  The role of visceral and subcutaneous adipose tissue fatty acid composition in liver pathophysiology associated with NAFLD.

Authors:  C L Gentile; T L Weir; K A Cox-York; Y Wei; D Wang; L Reese; G Moran; A Estrada; C Mulligan; M J Pagliassotti; M T Foster
Journal:  Adipocyte       Date:  2015-01-14       Impact factor: 4.534

4.  The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes.

Authors:  Scott A Sands; Kimberly J Reid; Sheryl L Windsor; William S Harris
Journal:  Lipids       Date:  2005-04       Impact factor: 1.880

5.  Distinct gene expression profiles characterize cellular responses to palmitate and oleate.

Authors:  Swapan K Das; Ashis K Mondal; Steven C Elbein
Journal:  J Lipid Res       Date:  2010-04-20       Impact factor: 5.922

6.  Determinants of Blood Cell Omega-3 Fatty Acid Content.

Authors:  Robert C Block; William S Harris; James V Pottala
Journal:  Open Biomark J       Date:  2008

7.  Effect of a sustained reduction in plasma free fatty acid concentration on insulin signalling and inflammation in skeletal muscle from human subjects.

Authors:  Hanyu Liang; Puntip Tantiwong; Apiradee Sriwijitkamol; Karthigayan Shanmugasundaram; Sumathy Mohan; Sara Espinoza; Ralph A Defronzo; John J Dubé; Nicolas Musi
Journal:  J Physiol       Date:  2013-03-25       Impact factor: 5.182

Review 8.  Basal insulin therapy.

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2004-10       Impact factor: 4.810

Review 9.  Which basal insulin should be used in patients with type 2 diabetes mellitus?

Authors:  John N Clore; Linda Thurby-Hay
Journal:  Curr Diab Rep       Date:  2007-10       Impact factor: 4.810

10.  Methylation patterns of Vegfb promoter are associated with gene and protein expression levels: the effects of dietary fatty acids.

Authors:  Roberto Monastero; Sara García-Serrano; Ana Lago-Sampedro; Francisca Rodríguez-Pacheco; Natalia Colomo; Sonsoles Morcillo; Gracia M Martín-Nuñez; Juan M Gomez-Zumaquero; Eduardo García-Fuentes; Federico Soriguer; Gemma Rojo-Martínez; Eva García-Escobar
Journal:  Eur J Nutr       Date:  2015-12-26       Impact factor: 5.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.